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ABSTRACT
Gut Microbiota Regulates the Interplay Between Diet and Genetics to
Influence Insulin Resistance
Jeralyn Jones Franson
Department of Microbiology and Molecular Biology, BYU
Master of Science
Insulin resistance and obesity are major public health concerns. The impact of diet and
genetics on insulin resistance and obesity is well accepted. Additionally, the gut microbiota has
been shown to influence obesity and metabolic disorders. However, much remains to be
understood about the role of gut microbiota in the development of insulin resistance and obesity.
We utilized a mouse model with a global deletion of PAS kinase, a protein involved in cellular
metabolism, to better understand the relationship between diet, genetics and the gut microbiota.
Previous research has shown that mutant mice, lacking PAS kinase, were protected from the
effects of a high fat diet, gaining less weight and showing a better response to insulin than high
fat diet fed wild-type mice. Surprisingly, when PAS-kinase knockout mice were placed on a
western-style, high fat, high sugar (HFHS) diet, they became obese and had an impaired
response to insulin, much like wild type mice on the same diet. Mutant mice did, however, show
more resistance to the effects of the unhealthy diet in one aspect—they maintained normal levels
of claudin-1 in the colon, suggesting that they were less likely to develop excessive gut
permeability (leaky gut). While significant differences in gut microbial composition were seen in
response to the HFHS diet, with shifts in the ratio of Firmicutes/Bacteroidetes and increases in
the levels of Actinobacteria, none of the differences correlated with genotype. Unexpectedly,
however, within the mice on the HFHS diet and regardless of genotype, the composition of the
gut microbiota diverged into two clusters. The mice in one cluster showed more resistance to
obesity and their glucose response was like that of wild type mice on a healthy normal chow diet
(NCD), while mice in the other cluster showed more weight gain and impaired glucose response.
No similar gut microbiota divergence occurred in mice on the NCD, suggesting that the HFHS
diet made mice vulnerable to (but did not cause) the development of a harmful gut microbiota,
whereas the healthy NCD protected against spontaneous harmful shifts in the composition of the
gut microbiota.
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Introduction
Obesity and Insulin Resistance
Insulin resistance and obesity are a major public health problem. Obesity affects 39.8 %
of adults in the United States 1 (Figure 1) and its prevalence is increasing worldwide 2. Body
mass index (BMI) is calculated by dividing weight in kilograms by the square of height in
meters, and obesity is defined as a BMI of 30 kg/m2 or greater. Obesity often occurs alongside
metabolic disease, which symptomatically manifests as elevated levels of fasting blood glucose,
liver triglycerides and blood pressure, as well as lower levels of high-density lipoprotein 3.
Obesity can lead to type 2 diabetes, certain cancers, cardiovascular diseases, stroke, and nonalcoholic fatty liver disease 4-7.
In healthy individuals, increased blood glucose levels trigger beta cells in the pancreas to
produce insulin. Extracellular insulin can subsequently bind to insulin receptors on cellular
membranes 8, allowing for increased glucose uptake by the cell by translocating glucose
receptors to the cellular membrane, and stimulating glycogen synthesis 9. A decrease in the cell’s
sensitivity to insulin is known as insulin resistance, and it can then lead to hyperglycemia,
hepatic lipid synthesis and adiposity 10. The severity of insulin resistance is used to classify
individuals as either prediabetes or type 2 diabetes. Prediabetes, which affects 33.9% of adults in
the United States (Figure 1), involves a fasting blood glucose between 100-125mg/dL11. A
fasting blood glucose above 125 mg/dL is indicative of type 2 diabetes, which has been
diagnosed in 8.6% of adults in the US (Figure 1) 11. Of adults diagnosed with diabetes, 87.5%
were overweight or obese 12.

1

Figure 1. Growth rates of obesity and Diabetes in the United States. From National Diabetes Statistics Report, 2017.
Centers for Disease Control and Prevention

Diet and the Gut Microbiota
Diet plays an important role in the development of obesity and insulin resistance. Adults
in the United States consume 14.9% of their daily calories from sugar 13. Overconsumption of
sugars can lead to metabolic disease 14 and a high-fat diet is a significant driver in the
development of obesity 15. Between 2013 and 2016, 37% of adults in the United States ate fast
food, typically high in fat, sugar and calories, on a given day 16.
In addition to over nutrition’s caloric contribution to obesity, the influence of diet on
obesity and insulin resistance can be traced through the direct effect diet has on the gut
microbiota. The gut microbiota refers to the collection of microorganisms that inhabit the
intestinal tract. Over 1000 bacterial species have been identified in the human intestine 17, with
populations ranging from 103 bacterial cells/gram of tissue (bacteria/g) in the duodenum, 104
bacteria/g in the jejunum, 107 bacteria/g in the ileum and 1012 bacteria/g in the colon18. The
2

duodenum, jejunum and ileum have a higher prevalence of Firmicutes (Lactobacillacea family),
Proteobacteria, and Actinobacteria, while the colon has a higher prevalence of Bacteroidetes,
Firmicutes (Lachnospiraceae and Ruminococcaceae families), and Verrucomicrobia
(Akkermansia genus)18. This diverse collection of bacteria exists in a delicate dance with the
host, as the bacteria are influenced by immune cells and nutrients provided by the host, and the
host’s health is subsequently affected by the bacteria in a beneficial or detrimental manner.
Gut bacteria influence the host primarily through by-products of their metabolism. The
gut microbiota is responsible for the breakdown of complex polysaccharides otherwise
undigestible by the host. Conversion of complex polysaccharides into short chain fatty acids
(SCFA) and fermentation in the colon supplies 10% of the host’s daily energy requirements 19.
SCFA include acetate, a substrate for gluconeogenesis and lipogenesis, propionate, a regulator of
immune function and intestinal physiology 19 and butyrate, a regulator of intestinal barriers 20.
The gut microbiota also plays a key role in the development and stimulation of immune function
21

, with SCFA playing a key role in the communication between the host immune system and

microbiota 22. The gut microbiota is also the sole supplier of essential vitamins, including
vitamins B and K 23.
The gut microbiota plays an important role in the development of obesity and insulin
resistance. The link between obesity and the gut microbiota was first shown by Gordon et al 24,
with shifts in the ratio of Bacteroidetes, a Gram-negative bacteria, and Firmicutes, a Grampositive bacteria, in genetically obese mice. Further studies also showed a preponderance of
Firmicutes in both obese human subjects 7 and high-fat fed mice 25. Additionally, studies showed
that transplantation of microbiota from obese human donors into germ-free mice led to the
development of weight gain and insulin resistance 26-29. Specific strains of bacteria isolated from
3

human hosts and transplanted into germ free mice were shown to induce the correlated
phenotype (either lean or obese) found in the host. Enterobacter cloacae B29, isolated from the
microbiota of an obese human patient (BMI 58.78 kg/m2) , induced obesity when transferred into
high-fat fed germ free mice, whereas germ free mice on the high fat diet that did not receive the
B29 transfer remained lean. 27. Bifidobacterium pseudocatenulatum C95, isolated from the gut
bacteria of type 2 diabetes patients assigned a high-fiber diet and probiotics, is associated with
improved hypoglycemia when transferred into high-fat fed germ free mice 30. Akkermansia
muciniphila, found in the gut microbiota of both humans and mice, is linked to improved glucose
tolerance and body weight in both humans and mice 29,31,32.
The role of diet on the gut microbiota has been further elucidated through studies on
germ free mice. Germ-free mice on a high-fat diet were protected from obesity and insulin
resistance 33. In conventional (not germ-free) mice, a high-fat diet alters the gut microbiota, and
subsequent alteration of the microbiota through administration of oral antibiotics ameliorated the
effects of a high-fat diet on weight gain, adiposity, glucose intolerance and inflammation 25. A
high-fat high-sugar diet (HFHS) also alters the gut microbiota, and it increases intestinal
permeability 34. However, germ-free mice fed a HFHS diet did not develop obesity or insulin
resistance 26, suggesting a causal role for the gut microbiota in the development of diet-induced
obesity and insulin resistance.
Intestinal Permeability
The exact mechanisms by which gut bacteria influence weight gain and insulin resistance
are unknown but may be related to the inflammatory response triggered by lipopolysaccharide
(LPS), an endotoxin from the cell walls of gram negative bacteria. Dietary sugar has been shown
to lead to increased hepatic fat and translocation of LPS from the intestines into the bloodstream
4

of mice 35. Elevated levels of circulating LPS are also correlated with obesity and insulin
resistance 25,34. LPS can pass through the intestinal epithelium into the bloodstream when tight
junctions between epithelial cells are disrupted. Claudin-1, zonula occludens-1, and occludin are
proteins in these epithelial barriers which play a crucial role in the regulation of intestinal
permeability 36. A high-fat diet has been shown to increase intestinal permeability 25 and
significantly decrease levels of tight junction proteins, including claudin 37.
Current research suggests the mechanism by which the gut microbiota influences levels
of tight junction proteins is via the Protein Kinase B (Akt) signaling pathway. LPS from gramnegative bacteria binds to toll like receptor-4 on the surface of a cell, which triggers the
production of inflammatory cytokines including tumor necrosis factor α (TNF-α) and NFκB 38,39.
In intestinal epithelial cells, NFκB activates inflammatory cytokines which inhibit the
Akt/mTOR signaling pathway 20. Inhibition of the Akt signaling pathway reduces levels of tight
junction protein expression 40.
Metabolic markers
In adipose, muscle, and liver tissue, the phosphoinositide kinase (PI3K) PI3K/Akt
signaling pathway plays a key role in metabolism and the development of type 2 diabetes and
obesity 41. Insulin secreted from the pancreas after eating activates the PI3K/AKT pathway
(Figure 2). Akt is activated by phosphorylation first at threonine 308 42, then at serine 473 by
mTOR, through a PI3K-dependant mechanism 43. When activated, Akt signals for translocation
of glucose transporter 4 (GLUT4) to the cell membrane, allowing glucose uptake (42). Activated
Akt (pAktser473) also inhibits the insulin receptor substrate (IRS) 41. Reduced levels of pAktser473
are seen in mice fed a high-fat diet 44,45 and bama pigs fed a high-fat high-sugar diet 46. In the

5

liver of normal chow diet fed mice, pAktser473 levels were overexpressed in mutants lacking PerArnt-Sim (PAS) kinase, a metabolic protein 47,48.

Figure 2. Overview of the metabolic pathways associated with Akt in muscle tissue.

Genetics
Per-Arnt-Sim kinase (PASK) is a protein involved in detecting the energy of the cell and
regulating metabolism 49. Previous research has shown that PASK knockout mice on a high fat
diet were protected from insulin resistance and obesity and demonstrated increased cellular
metabolism 50. The exact role of PASK in the cell is still unknown, but it is thought to be closely
involved with AMPK, insulin gene expression, and glucagon secretion 51,52. In this research we
examined the role that gut microbiota play in metabolic health and their ability to override
genetic influences to induce obesity and insulin resistance.

6

Hypothesis
The original aim of this research project was to determine whether PASK-deficient mice
would still be protected from weight gain and insulin resistance when placed on a Western diet-one high in both fats and sugars. We also wanted to analyze whether the gut bacteria of PASKdeficient mice would reflect diet or genotype. The role PASK may play in the composition of the
gut microbiota had not been studied previously. We hypothesized that microbiota primarily
contribute to any difference in glucose sensitivity by triggering systemic inflammation. This
could occur if certain bacteria secrete metabolites that increase gut permeability, which would be
reflected by reduced levels of claudin-1. Increased gut permeability should lead to LPS
circulating in the blood as well as circulating cytokines. The subsequent inflammatory response
will affect activation of Akt in the muscle, resulting in insulin resistance.
This research illuminated the role bacteria play in overriding genetics to influence
metabolic health. Understanding this role, and the cellular response to inflammatory signals,
could help us create better treatments and preventions for insulin resistance.
Study design
Animals
Housing: All procedures were carried out with the approval of the Institutional Animal Care and
Use Committee (IACUC) of Brigham Young University (protocols 16-1003 and 13-1003). 2
male and 1 female PASK +/- mice were obtained from the Rutter lab 53 and bred to produce the
colony used for this study. Upon weaning at 3 weeks of age, littermates were randomly assigned
to either a normal chow diet (NCD) (8604; Tekland Diets, Madison, WI; protein 32% kcal, fat
14%, carbohydrate 54%) or a western-style high-fat, high-sugar diet (HFHS) (D12266Bi;
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Research Diets, Inc., New Brunswick, NJ; protein 16.8% kcal, fat 31.8%, carbohydrate 51.4%).
Mice were co-housed according to sex, genotype, and assigned diet. All mice were housed with
no more than five mice per cage, on a 12-hour light/dark cycle. Water and food were freely
available.
Genotyping: PASK genotypes were determined by genomic polymerase chain reaction (PCR) of
tail snip specimens. Tails were digested in 100 µl lysis buffer (10 ml 1M Tris-HCl, pH 8.0, 1 ml
.5 M EDTA, pH 8.0, 4ml 5 M NaCl, ddH20 to 100ml) and 5 µl proteinase K overnight (14-16
hours) at 50 °C, shaking at 90-98 RPM. Samples were then boiled for 5 minutes and stored at
4°C. PCR was performed using 1µl ddH20, 2.5 µl 10µM forward PASK primer (5’GAAGTCACCCCCGATCCCCTCCTAAC-3’), 1.25 µl 10µM PASK MUT primer(5’ACTTTCGGTTCCTCTTCCCATGAATTC-3’), 1.25ul 10µM PASK WT primer(5’CTAGCCATGGTGCTTACCCTC-3’), 6.5 µl GoTaq GreenMaster Mix (Promega, Madison,
WI), and 2 µl template DNA for a total volume of 14.5µl per sample. Lid 100°C, (94°C for
20seconds, 64°C for 30 seconds, 70°C for 35 seconds) x30. Hold at 4°C. Bands were checked on
a 1.4% agarose gel using 6µl of PCR product (Figure 3).
Weekly weight and fecal collection: To track changes in weight and gut microbial contents, mice
were weighed weekly and fecal samples were collected. Fecal samples were placed into a sterile,
labeled Eppendorf tube and immediately placed on dry ice until storage at -80°C.
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Figure 3. Representative image of genotyping results.

Insulin tolerance (ITT) and glucose tolerance testing (GTT) : All mice were fasted 6 hours prior
to both GTT and ITT, with water freely available. Blood glucose levels were measured using the
TRUEresult glucometer (Nipro diagnostics, Fort Lauderdale, FL). GTT was administered every
four weeks at 3, 7, 11, 15, 19, and 23 weeks after weaning (Figure 4). A 20% glucose solution in
PBS was injected intraperitoneally (IP) at a dose of 1mg/g body weight. An initial blood glucose
reading was taken before injection with glucose. Blood glucose samples were measured at 5, 15,
30, 60, 90 and 120 minutes after injection. ITT was administered every four weeks at 16, 20 and
24 weeks after weaning (Figure 4). An initial blood glucose sample was measured, then 0.375
units/kg body weight of 0.5 U/ml insulin was administered IP (Humulin R; Lilly, Indianapolis,
9

IN). Blood glucose levels were measured at 15, 30, 45, 60, 90, and 120 minutes after injection.
Mice with multiple readings below 20 mg/dL and demonstrating signs of insulin shock were IP
injected with 100 ul of glucose and removed from the analysis. Food was made readily available
and the mice were observed for recovery.

Figure 4. Outline of experimental plan. Dots indicate time points of experimental data collection.

Blood collection and tissue harvest: At 25 weeks of age mice were euthanized by cervical
dislocation. Fresh blood was collected into a sterile Eppendorf tube. After 30 minutes blood
samples were spun at 3000 rcf for 15 minutes at 4°C. The serum was collected and placed into a
sterile tube and stored at -80°C. Excised tissues were immediately placed into sterile tubes with
the following exceptions. The brain and pancreas were flash frozen on dry ice and then placed
into sterile tubes. The left gonadal and retroperitoneal fat pads were weighed and then placed
into sterile tubes. The liver was weighed, and the largest lobe was then divided into three
sections. The first section was placed into 4% paraformaldehyde. The remaining two sections
were placed into sterile tubes. The intestines were flushed with chilled PBS and then placed into
sterile tubes. Contents of the cecum were removed and stored in a sterile tube. All samples were
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then flash frozen in liquid nitrogen and stored at -80°C. Tissues not needed for this study have
been saved for subsequent work.
Metagenomic analysis of gut microbiota
Bacterial DNA extraction, isolation, and purification protocol: Bacterial DNA was isolated and
purified from fecal pellets stored at -80°C using the extraction protocol described in Godo 54 with
the following changes: samples were homogenized in the Next Advance Bullet Blender Storm
(Next Advance, Averill Park, NY), using 3.2 mm stainless steel beads (SSB32; Next Advance,
Averill Park, NY). Cells were then disrupted with 0.1 mm glass beads (GB01; Next Advance,
Averill Park, NY). After isolation, purified DNA was suspended in 10mM Tris (pH 8.5) and
stored at -20°C.
Purity and concentration checks: DNA concentration was measured by absorbance at 260 nm
(A260) and purity was estimated by measuring the A260/A280 ratio with a Nanodrop
spectrophotometer (Nanodrop Technologies, Wilmington DE) (Table 1). Integrity of purified
DNA was checked using 0.8% agarose gel electrophoresis with ethidium bromide staining
(Figure 5a).
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Table 1. Representative results of DNA concentration.

Sample
ID

ng/ul

A260

A280

260/280

260/230

Constant

Cursor
Pos.

Cursor
abs.

340
raw

21-4
12-6
21-7
22-1
23-1
23-3
25-2
25-3
25-6
28-7
31-5
31-7
38-5
32-7
33-7

83.99
17.07
33.22
24.72
15.97
34.72
77.81
78.03
28.93
77.36
77.83
146.04
83.91
31.69
52.25

1.680
0.341
0.664
0.494
0.319
0.694
1.556
1.561
0.579
1.547
1.557
2.921
1.678
0.634
1.045

0.878
0.230
0.360
0.279
0.184
0.380
0.849
0.853
0.328
0.926
0.892
1.566
0.977
0.334
0.585

1.91
1.49
1.84
1.77
1.73
1.83
1.83
1.83
1.76
1.67
1.74
1.87
1.72
1.90
1.79

1.47
0.48
1.04
1.17
0.94
0.83
1.26
1.30
0.70
0.70
1.04
1.28
0.98
1.05
0.84

50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00
50.00

230
230
230
230
230
230
230
230
230
230
230
230
230
230
230

1.144
0.713
0.638
0.424
0.340
0.836
1.239
1.202
0.832
2.198
1.499
2.290
1.713
0.601
1.251

0.021
0.230
0.080
0.040
0.058
0.127
0.126
0.092
0.023
0.062
0.546
2.524
1.161
0.178
0.223

Figure 5. Representative gels from fecal DNA isolation and library preparation. (a) Bacterial genomic DNA from
female week 22 samples. (b) Results from amplicon PCR, week 22 samples.
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Bacterial DNA library preparation and sequencing: 16S rDNA gene libraries were prepared
using the Mi-Seq protocol by Illumina with the following changes: Amplicon primer sequences
provided by the Liping Zhao lab, Shanghai Jiao Tong University, were used to amplify the
V3/V4 region of the 16S rDNA (Table 2), and integrity of PCR product was checked on 1.2%
agarose gels (Figure 5b). Ampure beads were used for PCR cleanup. Illumina Nextera XT v2
adapters (Table 3) were then added using the Illumina protocol. Following index PCR,
SequalPrep normalization plates (Invitrogen, Frederick, MD) were used for final DNA
normalization of all samples. For the first batch of gut microbiota sequencing on male week 22
mice, samples were normalized manually by determining the concentration of DNA by
Nanodrop then adjusting it appropriately (Table 4). Paired-end sequencing was performed on the
Illumina Hi-Seq 2500 platform in the BYU DNA Sequencing Center.
Table 2. Primer sequences for 16s amplification.

Forward

Reverse

PFV3V4
PFV3V4-1
PFV3V4-2
PFV3V4-3
PFV3V4-4
PFV3V4-5
PRV3V4
PRV3V4-1
PRV3V4-2
PRV3V4-3
PRV3V4-4
PRV3V4-5

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTCCTACGGGNGGCWGCAG
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCTCCTACGGGNGGCWGCAG
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGACTCCTACGGGNGGCWGCAG
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGACTCCTACGGGNGGCWGCAG
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGACTCCTACGGGNGGCWGCAG
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTATCTAATCC
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTGGACTACHVGGGTATCTAATCC
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGATGGACTACHVGGGTATCTAATCC
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCATGGACTACHVGGGTATCTAATCC
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACATGGACTACHVGGGTATCTAATCC
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Table 3. Plate layout and list of Illumina indexing adapters used in the sequencing library.
Nextera XT v2 Set
A
B
C

Primer set 1
N701-N715
N716-N729
N701-N715

Primer set 2
S502-S511
S502-S511
S513-S522

Table 4. Representative results of DNA concentration after PCR-based incorporation of Illumina adapters and cleanup.

Sample
ID

ng/ul

A260

A280

260/280

260/230

Constant

Cursor
Pos.

Cursor
abs.

340
raw

A1

21.10

0.422

0.235

1.80

2.90

50.00

230

0.146

0.440

A2

43.10

0.862

0.640

1.35

0.93

50.00

230

0.925

6.055

A3

7.10

0.142

0.123

1.15

3.88

50.00

230

0.037

0.436

A4

26.83

0.537

0.316

1.70

2.65

50.00

230

0.202

0.456

A5

17.62

0.352

0.210

1.68

2.49

50.00

230

0.142

0.445

A6

18.27

0.365

0.222

1.65

2.91

50.00

230

0.126

0.465

A7

10.96

0.219

0.160

1.37

4.55

50.00

230

0.048

0.437

A8

13.77

0.275

0.167

1.65

3.60

50.00

230

0.076

0.480

A10

8.60

0.172

0.127

1.35

3.37

50.00

230

0.051

0.453

A11

11.75

0.235

0.151

1.56

3.17

50.00

230

0.074

0.457

A12

27.79

0.556

0.331

1.68

2.82

50.00

230

0.197

0.457

B1

18.35

0.367

0.257

1.43

2.59

50.00

230

0.142

0.069

B1

17.36

0.347

0.193

1.80

3.32

50.00

230

0.105

0.444

Sequencing analysis: 16S rDNA sequences were analyzed using the QIIME2/2017.10. software
package 55. Read joining, denoising, demultiplexing, and feature assignments were accomplished
using the Dada2 56 plug-in. Forward reads were truncated 23 bp to trim amplicon primers.
Reverse reads were truncated at 249 and 240 base pairs to insure overlap of reads. Samples from
the created BIOM table 57 were then filtered to remove features that appear in less than 2 total
samples (singletons), samples that contain less than 10 features and features not assigned to at
least phyla level. Phylogenetic distances were computed using q2-feature-classifier 58 with naïvebayes fit 59. Alpha and beta diversity were calculated using core metrics rarefied to a sampling
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depth of 8000. Principle coordinate analysis (PCoA) visualizations were created using EMPeror
60,61

. Permutation Multivariate Analysis of Variance (PERMANOVA) 62 was used to compare

differences in beta diversity between groups. Alpha diversity was calculated using Faith’s
Phylogenetic Diversity (PD) and Kruskal-Wallis one-way analysis of variance 63,64. Taxonomy
was assigned using q2-feature-classifier plug-in 65 using Greengenes13_8 85% OTUs trained
with the following primer sequences: F-CCTACGGGNGGCWGCAG RGACTACHVGGGTATCTAATCC.
Immunoblotting
Homogenization : Colon and skeletal muscle samples were weighed and lysed in 2X RIPA
buffer volume/sample volume, with 10 µl/ml protease and phosphatase inhibitor cocktail
(#78440, Thermo Fisher, Rockford, IL). All samples were homogenized using the Bullet Blender
Storm 24 (Next Advance, Averill Park, NY). Samples were homogenized using 0.9-2 mm
stainless steel beads. Muscle samples were homogenized at speed 10 for 4 minutes and colon
samples were homogenized at speed 12 for 3 minutes. Following homogenization and lysis,
samples were centrifuged at 16,000 rcf for 10 minutes and the supernatant was collected and
stored at -80°C.
Protein assay : Protein levels were quantified using the Pierce BCA Assay Kit (Thermo Fisher,
Rockford, IL) and a microplate reader (BioTek , Minooski, VT). Due to high protein
concentration, colon and muscle samples were diluted 1:10 and 1:100 respectively for accuracy
in detection. A linear equation was extrapolated using protein standards and associated optical
density readings (Figure 6), and protein concentration of unknown samples was estimated using
that equation (Table 5).
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Figure 6. Representative results from protein quantification. 1:100 serial dilution of muscle lysates.
Table 5. Representative results of protein concentration.

id

average od

protein ug/ml

46-7

0.3155

28605.77

59-3

0.365

36538.46

41-2

0.2925

24919.87

62-1

0.3115

27964.74

42-7

0.2615

19951.92

41-5

0.2545

18830.13

59-4

0.3785

38701.92

34-4

0.3965

41586.54

40-4

0.3085

27483.97

Protein sample preparation : Equal amounts of protein from colon lysates (Table 6) were
combined with 5X Lane Marker Sample Buffer (Thermo Fisher, Rockford, IL), heated in a
boiling water bath for 5 minutes, and then loaded onto a 4-15% SDS-PAGE gradient miniPROTEAN TGX gel,15 µl/well volume (Bio-Rad, Hercules, CA) for separation. Muscle samples
were treated with 2X Laemmli Sample Buffer (Bio-Rad, Hercules, CA), heated for 5 minutes in
boing water and loaded onto an Any kD mini-PROTEAN TGX gel, 20 µl/well volume.
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Table 6. Representative table of loading volumes of muscle lysates for immunoblotting.

ID average od
46-7
0.3155
59-3
0.365
41-2
0.2925
62-1
0.3115
42-7
0.2615
41-5
0.2545
59-4
0.3785
34-4
0.3965
40-4
0.3085
46-5
0.3025
38-5
0.3135
36-1
0.302
23-3
0.349
28-7
0.3585
43-8
0.3355

protein
ripa vol sample
loading
vol (30
(5 ul
protein
ug)
total) buffer vol total vol
amt(x100)
28605.77
1.05
3.95
5
36538.46
0.82
4.18
5
24919.87
1.20
3.80
5
27964.74
1.07
3.93
5
19951.92
1.50
3.50
5
18830.13
1.59
3.41
5
38701.92
0.78
4.22
5
41586.54
0.72
4.28
5
5
27483.97
1.09
3.91
5
26522.44
1.13
3.87
28285.26
1.06
3.94
5
5
26442.31
1.13
3.87
33974.36
0.88
4.12
5
35496.79
0.85
4.15
5
5
31810.90
0.94
4.06

10
10
10
10
10
10
10
10
10
10
10
10
10
10
10

Immunoblotting : An internal standard (WT-NCD) was included on every gel for normalization
comparison between gels. Semi-dry electrotransfer of proteins to a 0.45µm nitrocellulose
membrane in transfer buffer (20% methanol in tris/glycine buffer) was performed using the BioRad Trans-Blot Turbo (Invitrogen, Carlsbad, CA) mixed MW midi program. After transfer to the
nitrocellulose membrane, non-specific proteins were blocked in a 5% milk solution (7.5 g nonfat dry milk, 150 ml 1X tris-buffered saline (TBS)) and washed in TBST, 0.5ml Tween-20 in 1L
TBS. The membrane was then incubated overnight with primary antibodies at 1:1000 dilution
(TNF-α, claudin-1, β-Actin, GAPDH, Akt, pAkt(Ser473) Cell Signaling, Danvers, MA), diluted
in BSA (2.5g bovine serum albumin in 50 ml TBST). Muscle samples were probed for GAPDH
as a loading control. β-Actin was used as a loading control in liver and colon samples. Following
overnight incubation and washing, the membrane was then incubated for 60 minutes under foil
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with secondary antibodies, 1:10,000 dilution (IRDye 680RD goat/anti-rabbit, IRDye 800CW
donkey/anti-mouse LI-COR, Lincoln, NE) in BSA and washed with TBST.
Imaging and quantification : Membranes were imaged (Figure 7) on the LI-COR reader using
default parameters. Protein expression levels were evaluated and using the LI-COR imaging
software. The resulting readings were then normalized against the WT-NCD control. β-actin
levels were used as a loading control, and any samples with β-actin <0.7 or >1.3 relative to the
control lanes were discarded (Table 7).

Figure 7. Representative image of Western Blot.

18

Table 7. Representative normalization and quantification of western blot band densities from Figure 7. Highlighted
values (upper Claudin-1, ex. 2.15Claudin-1) values were discarded from analysis due to low relative control (lower
β-actin, ex 2.15B-actin) values.

Statistical Analysis
All data are shown as mean ± SEM using GraphPad Prism 7.0. Multiple groups were
analyzed using ANOVA with Sidak’s or Tukey’s multiple comparisons test in GraphPad Prism.
Alpha diversity of microbiota data was analyzed using Kruskal-Wallis one-way ANOVA 63.
Permutation Multivariate Analysis of Variance (PERMANOVA) 62 was used to compare
differences in beta diversity between groups. Area under the curve was calculated with a baseline
of 0. Significance levels were assigned as p<0.05; *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001. Tertiles were assigned by sorting each group sequentially and dividing the
rankings into thirds.
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Results
PASK deletion does not protect against weight gain on a HFHS diet.
The aim of this research was to determine whether PASK-deficient mice would be
protected from weight gain and insulin resistance when placed on a Western diet--one high in
both fats and sugars, as when fed a high-fat only diet 47,49. Significant increases in weekly weight
gain were seen in both PASK+/+ (WT-HFHS) and PASK-/- (MUT-HFHS) (Figures 8a and 8b)
male mice on the HFHS diet over time. Additionally, both WT-HFHS (p=0.0010) and MUTHFHS (p=0.0246) had significantly higher final body weights when compared to NCD (Figure
8c). However, no significant differences in weight gain or final weights were seen between the
genotype groups on either diet. Likewise, relative weights of whole liver (WT p=2.472e-009,
MUT p=1.218e-007), as well as gonadal (GFP) (WT p=0.0511, MUT p=0.01091) and
retroperitoneal fat pads (RFP) (WT p=0.0021, MUT p=2.47e-005) showed differences reflective
of diet, not genotype (Figures 8d, 8e, and 8f).
Results of weight gain in the female mice showed that the MUT-HFHS mice gained more
weight overall than all other groups (Figure 8h), with significant differences in final weights
between MUT-HFHS and WT-HFHS (p=.00024) and MUT-NCD (p=0.0002) (Figure 8i).
Unfortunately, female WT-HFHS mice failed to gain more weight than wild type females on the
normal chow diet (WT-NCD) (Figure 8g). All female mice were subsequently dropped from the
analysis due to failure to validate the method of inducing weight gain through HFHS diet in the
control group.
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Figure 8. Diet, not genotype, influences body and tissue weight. (a) Weekly body weight gain of WT male mice by
diet. Significant differences emerged after 11 weeks on the diet (p<0.05). (b) Weekly body weight gain of MUT
male mice by diet. (c) Male final body weights. (d-f) Relative tissue weights at dissection of liver, gonadal fat pad,
and retroperitoneal fat pad expressed as tissue weight/final body weight. (g, h) Female weight gain by week. (i)
Female final weights. All data is expressed as mean ± SE. All groups n=13-19.
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PASK deletion does not significantly alter blood glucose levels.
Previous research has shown deletion of PASK imparts a protective effect against highfat diet-induced insulin resistance 47,53. Our research showed no significant differences in fasting
blood glucose levels between the groups (Figure 9a). Additionally, no significant differences
were seen in glucose response or area under the curve between all mice in the groups at midtesting, 15 weeks (Figures 9b and 9c), 19 weeks (Figures 9d and 9e) or the final time point, 23
weeks (Figures 9f and 9g). There was a trend seen with ITT response at 16 weeks between
MUT-NCD and MUT-HFHS mice (Figures 10a and 10b), but any differences failed to repeat in
subsequent tests (Figures 10c and 10d).

Figure 9. WT and MUT mice show no difference in glucose tolerance. (a) Fasting blood glucose levels after 3, 15,
and 23 weeks on diet. (b-e) Blood glucose levels during IP gluocose tolerance testing and area under the curve. All
groups n=12-15.
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Figure 10. Insulin tolerance testing showed no differences between groups. (a) week 16 (b) week 16 AUC (c) week
24 (d) week 24 AUC. All groups n=12-15

Claudin-1 expression is dependent on diet.
To better understand the increased weight gain and insulin resistance seen in the MUTHFHS mice, protein levels of claudin-1 in the colon, and Akt and pAkt in skeletal muscle were
measured by immunoblotting. Claudin-1 is a membrane protein involved in forming the tight
junctions between intestinal endothelial cells. Claudin-1 levels have been shown to be reduced in
mice on a high-fat diet 37. Colon claudin-1 expression significantly decreased in WT-HFHS mice
compared to WT-NCD mice (Figure 12a, p=0.0004). Surprisingly, MUT-HFHS mice showed
increased claudin-1 expression when compared to WT-HFHS mice (Figure 11a, p=0.007).
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Akt levels in the skeletal muscle show a decreasing trend in MUT-NCD when compared
to WT-NCD mice (Figure 11b p=0.06). Akt expression levels were similar between all mice on
the HFHS diet and WT-NCD mice. Relative levels of activated Akt (pAkt ser473) decreased in
mutants, with significant decreases seen in the MUT-HFHS mice (Figure 11c, p=0.01) when
compared to WT-HFHS, conflicting with the Claudin-1 results and previously published liver
data from high-fat fed PASK knockout mice 48.

Figure 11. Diet and genotype induced changes in protein levels. (a) Colon claudin-1 levels. N=5-7 per group. (b)
Muscle Akt levels. N=3-5 per group, (c) Muscle pAkt(ser473) levels. N=4-5 per group. Representative immunoblots
are shown.

The gut microbiome reflects diet, not genotype
To study the effects of PASK and diet on the gut microbiota, fecal samples collected after
22 weeks on the diet were selected for bacterial DNA isolation and sequencing. This time point
was chosen for maximum length of time on the diet, and longest amount of time after blood
glucose testing (2 weeks) to minimize any effects of stress. Preliminary results of the unweighted
Unifrac principle coordinate analysis (PCoA) plot showed a clear separation by diet with the
NCD mice closely clustered together (Figure 12a, blue dots). Genotype did not influence
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separation of the samples with both genotypes equally dispersed among diet groups (Figure 12b).
Mutant samples on the HFHS diet showed a separation into two clusters, yellow and orange
circles, (Figure 12d), with the differences in microbiota composition reflected in a poor response
to glucose at 15 weeks in the upper/orange cluster, (Figure 12c). “Because the difference in
glucose response was more pronounced at 15 weeks (Figure 12c) than at 22 weeks (not shown),
another batch of 16S rDNA gut microbiota sequencing was performed using samples collected
after 15 weeks on the diet. To minimize variability, 22-week samples were re-sequenced with the
15-week samples.

Figure 12. Microbial composition influenced glucose tolerance at 15 weeks. Unweighted Unifrac PCoA plots of
male, week 22 samples coded by (a) diet (b) genotype (c) glucose tolerance results of MUT-HFHS males separated
by cluster. (d) Unweighted UniFrac PCoA plot coded by body weight tertile
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Gut microbiota composition is determined by diet, not genotype
When comparing genotype, samples taken after both 15 and 22 weeks on the diet showed
no differences in alpha diversity (Faith’s Phylogenetic Diversity) 64 (15-week HFHS n=12-13,
p=0.586; NCD n=10-11, p=0.324. 22-week NCD n=13-16, p=0.93. HFHS n=12-15, p=0.96)
(Figure 13a) or beta diversity (unweighted Unifrac)66 (15-week NCD p= 0.314, HFHS p=0.672.
22-week NCD p=0.183, HFHS p=0.579) (Figure 13b). Diet however, played a significant role in
shaping differences in alpha (15-week n=21-25, p=0.00002 H=18.2, q=0.0002. 22-week n=2729, p=0.002 H=9.55) (Figure 13c) and beta diversity after both 15 and 22 weeks on the diet (15week p= 0.001, 22-week p=0.001) (Figure 13d). Differences in diversity were reflected with
increases in the relative abundance of Actinobacteria in mice on the HFHS diet after both 15
(Figure 13e) and 22 weeks on the diet (Figure 13f) and a decrease in the abundance of
Bacteroidetes only after 22 weeks (Figure 13f). These results suggest that diet played the
determinative role in the composition of the gut microbiota.
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Figure 13. Diet, not genotype, influences gut microbial diversity. Alpha diversity is measured by Faith’s
Phylogenetic Diversity. Beta diversity is a measurement of. (a).Comparison of Faith’s Phylogenetic Diversity
between genotypes (b) Comparison of unweighted UniFrac distances by genotype (c) Comparison of Faith’s
Phylogenetic Diversity between NCD and HFHS (d) Comparison of unweighted UniFrac distances between NCD
and HFHS. (e) Relative abundance at phyla level of week 15 samples. (f) Relative abundance at phyla level of week
22 samples. Alpha diversity is expressed as mean plus SEM, distances to NCD with Kruskal-Wallis follow-up. Beta
diversity is expressed as mean plus SEM with PERMANOVA comparison.
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Bacterial composition is associated with weight gain and glucose response in HFHS mice.
To further study the roles diet and microbiota composition played in the development of
obesity and glucose intolerance, we analyzed Unweighted Unifrac Principle Coordinate Analysis
(PCoA) results. After the second round of sequencing, week 15 PCoA results reflected
separation only by diet (Figure 14a). Week 22 PCoA results showed the same separation of the
HFHS mice into two distinct groups (Figure 14b) as was seen previously (Figure 12d). HFHS
mice that fell into the upper third of final body weight per group (1st tertile, triangles) were all in
the lower (orange oval) cluster on the PCoA plot (Figure 14b). This cluster showed higher levels
of Firmicutes and Bacteroidetes (Figure 14c) and is reflected in Unweighted Unifrac distances
between the first tertile of final body weight and the second tertile in HFHS week 22 samples
(Figure 14d) (p=0.003), but not in the 15-week samples, suggesting the microbiota shift in the
HFHS developed over time. The HFHS lower cluster also had significantly higher final body
weights (Figure 14e) when compared to the WT-NCD (p=0.0478), whereas the HFHS upper
cluster did not (p=0.1854). These data suggest the microbiota shift that occurred in some mice on
the HFHS diet was a factor in the development of obesity.
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Figure 14. Gut microbial composotion influences weight gain. (a) Unweighted UniFrac PCoA plot of week 15
samples. (b) Unweighted UniFrac PCoA plot of week 22 samples coded by final body weight tertile per group,
orange oval outlines the HFHS lower cluster, yellow oval outlines the HFHS upper cluster. (c) Heatmap of week 22
male HFHS samples sorted by final body weight tertile. (d) Comparison of unweighted UniFrac distances by final
body weight tertile of HFHS males. (e) Final body weights of HFHS mice divided by unweighted UniFrac PCoA
cluster.
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Comparison of glucose responses between the two clusters revealed neither cluster was
significantly different from WT-NCD at week 15 GTT (Figure 15a and Figure 15b, p= 0.0961)
An impaired glucose response in the lower cluster was seen at week 19 GTT (Figure 15c and
Figure 15d, p=0.0040), and week 23 GTT (Figure 15e and Figure 15f, p=0.0185) when
compared to WT-NCD. When GTT results were divided into tertiles, mice whose week 19 GTT
AUC results were in the top (worst) tertile for their group were all in the lower gut microbiota
cluster (Figure 15g), and their gut microbiota showed a separation from the middle tertile
reflected in unweighted UniFrac distances (Figure 15h) (p=0.015). Similar separation by GTT
tertile were not seen at the 15-week timepoint (Figure 15h), again suggesting that the gut
microbiotas shifted over time. ITT results were not correlated with microbiota composition
(week 16 ITT AUC p=0.2916, Figure 15i; week 24 ITT AUC p=0.3839, Figure 15j).
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Figure 15. Gut microbial composition influences glucose response. (a) Week 15 GTT. (b) Week 15 AUC. (c) Week
19 GTT. (d) Week 19 AUC. (e) Week 23 GTT. (f) Week 23 AUC. (g) Unweighted UniFrac PCoA plot of week 22
samples coded by tertile of AUC by group. (h) Comparison of unweighted UniFrac distances of week 19 AUC
tertile. (i) Week 16 ITT AUC (j) Week 24 ITT AUC.
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To determine whether genotype played any role in the gut microbiota divergence, we
compared glucose response by diet and genotype in the upper and lower clusters against WTNCD mice. The lower cluster of MUT-HFHS showed the most consistent impaired glucose
response (Figure 16) with the greatest differences seen after 19 weeks on the diet (Figure 16d)
(p=0.02). No significant differences were seen in glucose response between the MUT-HFHS
upper and MUT-HFHS lower groups after 15 weeks on the diet when WT-HFHS mice were
included in an ANOVA analysis (Figure 16b) (p=0.0772). But when the MUT-HFHS upper and
lower group were compared via Student’s T-test, there were significant differences in AUC
between the two groups at 15 weeks (p=0.0211). At week 19 both the MUT-HFHS lower group
(p=0.05), and the WT-HFHS lower group (p=0.0487) had greater AUC when compared to the
WT-NCD group. At the 23-week timepoint (Figure 16f), only the MUT-HFHS lower group was
significantly different from the WT-NCD group (p=0.0488). These results suggest that the MUTHFHS mice showed a greater susceptibility to the shift in the microbiota.

Figure 16. Genotype and microbial composition influences glucose response.(a) Week 15 GTT. (b) Week 15 GTT
AUC. (c) Week 19 blood glucose. (d) Week 19 AUC. (e) Week 23 blood glucose. (f) Week 23 AUC.
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Protein expression is linked to genotype and microbiota composition
To study the effect microbiota composition had on protein expression, we compared the
upper and lower groups. A HFHS diet significantly decreased claudin-1 expression in both the
upper and lower groups (Figure 17a). The HFHS lower cluster had considerably lower levels of
claudin-1 compared to both the WT-NCD (p<0.001) and HFHS upper cluster (p=0.0377),
suggesting a further deleterious effect provided by the microbiota in the lower cluster.
When separated by genotype, a HFHS diet significantly decreased claudin-1 expression
in both the upper (p=0.0012) and lower (p=0.0001) WT groups and the MUT-HFHS lower group
(p=0.0453) (Figure 17d) when compared to WT-NCD. Interestingly, however, the MUT-HFHS
upper group showed claudin-1 levels similar to WT-NCD (p=0.999), suggesting a protective
effect provided by deletion of PASK, which could be overcome by the microbiota in the lower
cluster.
Akt expression showed no significant differences between any of the groups, regardless
of diet, genotype, or microbiota clusters (Figure 17b and Figure 17e). Activated Akt (pAkt)
expression did not differ by cluster (Figure 17c). When separated by genotype, pAkt was
significantly elevated in the WT-HFHS lower group when compared to the MUT-HFHS lower
group (Figure 17f) (p=0.0026). These results suggest that microbiota composition only affected
claudin-1 expression.
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Figure 17. Microbiome influences changes in protein expression. (a)Comparison of relative expression of claudin-1
by unweighted UniFrac PCoA cluster. (b) Comparison of relative expression of Akt by unweighted UniFrac PCoA
cluster. (c) Comparison of relative expression of pAkt by unweighted UniFrac PCoA cluster. (d) Comparison of
relative expression of claudin-1 by unweighted UniFrac PCoA cluster and genotype. (e) Comparison of relative
expression of Akt by unweighted UniFrac PCoA cluster and genotype. (f) Comparison of relative expression of
pAkt by unweighted UniFrac PCoA cluster and genotype.

Discussion
Rates of obesity and insulin resistance in the United States are increasing, necessitating
better animal models to better understand influencing factors. Deletion of PASK, a metabolic
protein, has previously been shown to protect mice against high fat diet-induced weight gain and
insulin resistance 47,50,53. In the current study, we placed PASK mutant mice on a western-style
HFHS diet rather than a high fat diet to examine its effects. Contrary to those previously
published studies, deletion of PAS-kinase did not protect mice from weight gain on a westernstyle, HFHS diet. Deletion of PASK also failed to protect mice from glucose intolerance or
insulin resistance. Mice of either genotype on the NCD, however, were protected from weight
gain, glucose intolerance and insulin resistance, suggesting that diet played an overarching role
in the development of poor metabolic health.
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Both diet and genotype influenced expression of the tight-junction protein claudin-1. In
wild type mice, the HFHS diet led to significantly less claudin-1 in the colon, whereas mutant
mice were protected against a HFHS-induced claudin-1 decrease. Decreased levels of tightjunction proteins in the gut have been shown to correlate with increased gut permeability and
systemic inflammation 25,34. This result, therefore, suggests that even though PASK mutant mice
were not protected against all of the harmful effects of the HFHS diet in this study (weight gain
and glucose intolerance), they did show some metabolic advantages over wild type mice.
Diet was the only variable seen to contribute to differences in microbial composition
between the groups, with the expected increases in Firmicutes and Actinobacteria seen in mice
on the HFHS diet 7,67. Genotype differences can influence microbiota composition. Unpublished
research by our lab showed that deletion of CD5 significantly altered the gut microbiota in mice
on NCD. Differences in gut microbiota were also seen in p66Shc -/- mice on a HFD 68. However,
in this study only diet correlated with composition of the gut microbiota.
One of the most interesting observations of this study was that within the HFHS mice of
both genotypes, a spontaneous shift or split occurred in the gut microbiota composition. This
split can be visualized in the unweighted UniFrac PCoA analysis shown in Fig. 14b. An
examination of the mice in these two microbiota clusters revealed that none of the mice in the
upper cluster were in the highest tertile of body weight. Mice in the lower microbiota cluster
showed significantly poorer glucose tolerance after both 19 and 23 weeks on the HFHS diet,
whereas mice in the upper microbiota cluster on the same diet showed a glucose response that
was indistinguishable from that of wild type mice on a healthy NCD.
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The cause of the divergence in microbiota composition between the two clusters in
unknown, however maternal influences are unlikely due to the similarity of the HFHS microbiota
at 15 weeks. All the mice were on the HFHS diet, and both clusters contained a mix of wild type
and mutant mice. It is possible that the microbiota shift happened in some mice due to stress,
which is a known disrupter of the gut microbiota 69. This study extended across an 18-month
window, and possible stressors include moving to a new building, building vibration due to
neighboring construction projects, and many different experimenters and caretakers. Acute stress
can also alter tight junction protein expression 70 20, providing another potential explanation for
the differences in claudin-1 expression.
A key observation of this study is that no gut microbiota divergence was detected in mice
on the healthy NCD. This suggests that a healthy diet confers protection against potentially
harmful disruptions to the gut microbiota, whereas the western-style diet left mice vulnerable to
such disruption. Further studies controlling for stress as a variable, sequencing of additional
timepoints between 15 and 22 weeks, and examining individual species and strains to determine
which contributed to the harmful effects of the lower cluster gut microbiota may better explain
the clustering seen in the HFHS mice.
In summary, we found that microbial differences, not the deletion of PASK, had the most
profound influence on weight gain and glucose tolerance claudin-1in mice fed a high-fat diet.
Our findings also showed that the best predictor of metabolic health was a NCD, illustrating the
importance of diet on metabolic health.
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